Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folic Acid Ranks Fourth Among Recalled Birth Defect Prevention Methods

This article was originally published in The Tan Sheet

Executive Summary

Prenatal/multiple vitamin use was the fourth most remembered way to prevent birth defects among women interviewed in a March of Dimes' August survey entitled "Folic Acid and the Prevention of Birth Defects."

You may also be interested in...



Salma "marches" for folic acid

Actress Salma Hayek teams with the March of Dimes Birth Defects Foundation in a public service campaign to raise awareness of folic acid supplementation for the prevention of neural tube defects. The full-color ad will run in Vogue, Elle, Vanity Fair and other magazines and features an "attention-getting" photo of Hayek, along with the text, "Salma Hayek is not pregnant." The ad reinforces the need for women to take 400 mcg/day of folic acid well before they choose to have a child, the nonprofit group notes. The March of Dimes has been lobbying for the passage of the "Children's Health Act," which contains funding for folic acid research and outreach. The bill passed the House May 9 and was referred to the Senate Health & Education Committee. Companion legislation reportedly also is in the works (1"The Tan Sheet" May 15, p. 16)

Folic Acid, Birth Defects Research Addressed In Children's Health Bill

The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel